Trials / Conditions / Oncologic Disorders

Oncologic Disorders

23 registered clinical trials studyying Oncologic Disorders — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL) NCT07519811	Technical University of Munich	N/A
Recruiting	Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibr NCT06782412	KU Leuven	Phase 2 / Phase 3
Recruiting	Advanced Imaging Holistic Omics Biobank NCT06523270	IRCCS San Raffaele	—
Unknown	The Right to be Forgotten in the AYA Population: Patients' Experience and Perspectives (Diritto All'Oblio) NCT06229535	Centro di Riferimento Oncologico - Aviano	—
Recruiting	Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Card NCT05769868	Consorcio Centro de Investigación Biomédica en Red (CIBER)	Phase 3
Completed	Study of Factors Associated With Significant MYoCArdian Uptake on 68Ga-DOTATOC PET Scans for Oncology NCT05478733	Central Hospital, Nancy, France	—
Completed	Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survi NCT05132998	Associacao de Investigacao de Cuidados de Suporte em Oncologia	N/A
Completed	COVID-19 Vaccination in Oncologic Patients NCT04918888	Krankenhaus Barmherzige Schwestern Linz	—
Completed	Hepatitis E Virus Infection in Oncological Patients NCT06631560	Medizinische Hochschule Brandenburg Theodor Fontane	N/A
Unknown	Collaborative Network to Take Responsibility for Oral Anticancer Therapy 2 NCT04142463	Ilyse Kenis	N/A
Terminated	Nutrition Health Literacy of Cancer Patients and Their Support Networks. NCT03978312	Nottingham University Hospitals NHS Trust	—
Unknown	Disease Course in Oncological Patients During Inpatient Rehabilitation and After Three Months Follow-up NCT04842214	Klinik Valens	—
Completed	Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients NCT03030248	Medical College of Wisconsin	Phase 2
Completed	Place of General Medical During Oncology Care Management NCT03416465	Institut de Cancérologie de Lorraine	—
Completed	Clinical Use of Pathogen Reduced Red Blood Cell Suspension NCT03426553	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Phase 3
Unknown	Oncologic Therapy Support Via Means of a Dedicated Mobile App NCT03168048	Heidelberg University	N/A
Withdrawn	Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Stude NCT03041571	University of Florida	—
Completed	Effect of Warm Water Footbaths With Added Ginger or Mustard Powder on Psychosocial Parameters in Patients With NCT04271670	ARCIM Institute Academic Research in Complementary and Integrative Medicine	N/A
Completed	Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders NCT02484053	Baylor College of Medicine	EARLY_Phase 1
Completed	Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction NCT04420039	Hospital Universitari de Bellvitge	—
Terminated	The Needs and Burden of Family Caregivers of Older Adults With Cancer NCT02285296	University Hospital, Lille	N/A
Completed	Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device NCT01210716	Fenwal, Inc.	Phase 3
Completed	Prognostic Performance of the Naples Prognostic Score NCT03272646	University of Campania Luigi Vanvitelli	—